Waldencast sells Obagi Medical to Bridgepoint for up to $460M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. QGEN
7. CSX
8. LRCX
9. NDAQ
10. BFH

Go back to Waldencast sells Obagi Medical to Bridgepoint for up to $460M

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

July 30, 2026 4:30 PM EDT

LONDON, July 30, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (Waldencast or the Company) today announced that it completed the previously announced sale of its Obagi Medical dermatological skincare and aesthetics business (Obagi Medical) to Bridgepoint, one of the world's leading mid-market investors, in a transaction valued at up to $460 million (subject to negotiated deductions and customary adjustments based on closing cash, closing indebtedness, net working capital and transaction expenses), marking a significant step in Waldencasts strategy to strengthen its balance sheet and focus on accelerating the global growth of Milk Makeup.

As previously... More